Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the turbuhaler in asthmatic individuals
Autore:
Derom, E; Borgstrom, L; Van Schoor, J; Lofroos, AB; Pauwels, R;
Indirizzi:
State Univ Ghent Hosp, Dept Resp Dis, B-9000 Ghent, Belgium State Univ Ghent Hosp Ghent Belgium B-9000 sp Dis, B-9000 Ghent, Belgium AstraZeneca Res 7 Dev, Expt Med, Lund, Sweden AstraZeneca Res 7 Dev LundSweden eca Res 7 Dev, Expt Med, Lund, Sweden
Titolo Testata:
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
fascicolo: 8, volume: 164, anno: 2001,
pagine: 1398 - 1402
SICI:
1073-449X(20011015)164:8<1398:LDAPEO>2.0.ZU;2-#
Fonte:
ISI
Lingua:
ENG
Soggetto:
HISTAMINE-INDUCED BRONCHOCONSTRICTION; BRONCHIAL RESPONSIVENESS; AIRWAY RESPONSIVENESS; METHACHOLINE; INHALATION; SALBUTAMOL; REACTIVITY; CHALLENGE; RESPONSES; DRUGS;
Keywords:
drug aerosol therapy; bronchial asthma; antiasthmatic agents; adrenergic beta-agonists;
Tipo documento:
Article
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Life Sciences
Citazioni:
38
Recensione:
Indirizzi per estratti:
Indirizzo: Derom, E State Univ Ghent Hosp, Dept Resp Dis, De Pintelaan 185, B-9000 Ghent, Belgium State Univ Ghent Hosp De Pintelaan 185 Ghent Belgium B-9000 gium
Citazione:
E. Derom et al., "Lung deposition and protective effect of terbutaline delivered from pressurized metered-dose inhalers and the turbuhaler in asthmatic individuals", AM J R CRIT, 164(8), 2001, pp. 1398-1402

Abstract

We investigated the relationship between pulmonary deposition of terbutaline and bronchoprotection against methacholine and histamine with the Turbuhaler (AstraZeneca, Lund, Sweden) and a pressurized metered dose inhaler (pMDI) in 13 asthmatic patients. The study was done with a randomized, double blind, double dummy, and crossover design. On different days, the provocative concentration. of histamine causing a 20% decrease in FEV1 (PC20 histamine) and PC20 methacholine were determined before and at 1.5, 3, and 6 h after inhalation of 0.25 or 0.5 mg of terbutaline sulfate. The Turbuhaler delivered significantly more drug than did the pMDI (% of the nominal metered dose and 95% confidence interval): 20.8% (16.4 to 26.6%) and 16.9% (13.2 to 21.7%) versus 4.8% (3.8 to 6.1%) and 7.4% (5.8 to 9.5%), respectively. Average protection against histamine over 6 h was 0.66 (95% CI: 0.45 to 0.87) doubling concentrations (DC) after inhalation of 0.25 mg and 1.08 (95% Cl: 0.87 to 1.29) DC after 0.5 mg terbutaline via pMDI, and 1.07 (95% Cl: 0.87 to 1.29) DC after 0.25 mg and 1.24 (95% Cl: 1.03 to 1.45) DC after 0.50 mg via Turbuhaler. Protection against methacholine was also dose- and device-dependent. The dose needed to obtain the same pulmonary deposition with the pMDI was 3.14 times greater than with the Turbuhaler, and that needed for the same protective effect was. 2.1 and 3.2 times greater for histamine and methacholine, respectively. We conclude that pulmonary deposition of terbutaline was predictive of the clinical response.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 14:45:15